Arine
PrivateLast Round
Series C
Jun 24, 2025
Est. Valuation
$139M
Total Funding Raised
$70M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arine operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in June 2025.
Arine is a healthcare technology company that provides an AI-driven SaaS platform to optimize medication therapy and management for payers and at-risk providers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Vertical SaaS, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arine Comparables
Compare Arine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AdhereHealth | 81% | |
| RxAnte | 79% | |
| MedImpact Healthcare Systems | 76% |
For institutional investors. Book with your work email.
Arine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 24, 2025 | ||||
| Series B | Aug 17, 2022 | ||||
| Series A | Oct 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 111 West Capital | Series A, Series B |
| Town Hall Ventures | Series C |
| New Leaf Venture Partners | Series B |
| Kaiser Permanente Ventures | Series C |
| Super Capital Group | Series B |
| Super Capital Group | Series B |
| Katalyst Ventures | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Now managing over 18 million lives across health plan clients.
- Sep 10, 2025
Resonate, a flagship solution, has been launched.
For institutional investors. Book with your work email.
Arine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arine's valuation, stock price, and market status.
Is Arine a public or private company?
Arine is a private company.
What is the current stock price of Arine?
Arine is a private company, so its shares have no public market price. Caplight tracks Arine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arine worth (valuation)?
Arine's valuation is estimated at $139.0M based on funding round data.
Can I buy Arine stock?
Arine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arine's last funding round?
Arine's most recent funding round was Series C on June 24, 2025.
Who are the main investors in Arine?
Key investors in Arine include 111 West Capital, Town Hall Ventures, Katalyst Ventures.
Will Arine IPO soon?
No public IPO plans have been announced for Arine.
How can I track Arine secondary market activity?
Caplight tracks bids, offers, and trades in Arine's shares on secondary markets.